Decision-making model for early diagnosis of congestive heart failure using rough set and decision tree approaches. J Biomed Inform. 2012;45:999 1008. 19. Kelder JC, Cramer MJ, Van WJ, et al. The diagnostic value of physical ex- amination and additional testing in primary care patients with suspected heart failure. Circulation. 2011;124:2865 73. 20. Balion C, Don-Wauchope A, Hill S, et al. Use of Natriuretic Peptide Mea- surement in the Management of Heart Failure [Internet]. 13(14)-EHC118- EF ed. Rockville, MD: 2013. 21. Booth RA, Hill SA, Don-Wauchope A, et al. Performance of BNP and NT- proBNP for diagnosis of heart failure in primary care patients: a systematic review. Heart Fail Rev. 2014;19:439 51. 22. Dao Q, Krishnaswamy P, Kazanegra R, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care set- ting. J Am Coll Cardiol. 2001;37:379 85. 23. Davis M, Espiner E, Richards G, et al. Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet. 1994;343:440 4. 24. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B- type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161 7. 25. Moe GW, Howlett J, Januzzi JL, et al. N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective random- ized multicenter IMPROVE-CHF study. Circulation. 2007;115:3103 10. 26. Mueller C, Scholer A, Laule-Kilian K, et al. Use of B-type natriuretic pep- tide in the evaluation and management of acute dyspnea. N Engl J Med. 2004;350:647 54. 27. van Kimmenade RR, Pinto YM, Bayes-Genis A, et al. Usefulness of in- termediate amino-terminal pro-brain natriuretic peptide concentra- tions for diagnosis and prognosis of acute heart failure. Am J Cardiol. 2006;98:386 90. 28. 